This section is password-protected. Please use the group password to access the documents.
Will adjuvant pembrolizumab improve recurrence-free survival for patients with high-risk Stage III melanoma? 14/09/2015
Adjuvant Ipilimumab significantly effects recurrence-free survival in patients after resection of high risk lymph node p 20/04/2015
Pr Alexander Eggermont presented the initial efficacy and safety results from EORTC trial 18071 at ASCO 2014 in Chicago 11/06/2014
Vaccination with GM2-KLH-QS21 does not improve outcome stage II melanomas patients in EORTC study 13/09/2013
EORTC Melanoma Group study selects AS15 adjuvant for active immunization with MAGE A3 protein for treatment of metastati 29/05/2013
Gender plays a role in progression-free and disease-specific survival according to five EORTC studies in stage III-IV me 23/05/2013
EORTC Melanoma Group investigating use of PEG-IFN- α-2b for patients with stage II ulcerated primary cutaneous melanoma 16/01/2013